Skip to main content
OpenTrials

Clinical trial condition

Adult Glioblastoma

Explore clinical trials studying Adult Glioblastoma. Study availability and eligibility vary by location and protocol.

57 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Adult Glioblastoma trial results

Completed

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

NCT00329719

Conditions
Adult Glioblastoma, Adult Gliosarcoma, Astrocytoma, +18 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 190 locations
View Trial Details
Completed

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

NCT00433381

Conditions
Adult Glioblastoma, Adult Gliosarcoma, Astrocytoma, +18 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 93 locations
View Trial Details
Completed

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

NCT00335764

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

NCT01648348

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Saint Jude Medical Center Fullerton, California, United States
  • Saint Joseph Hospital - Orange Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 308 locations
View Trial Details
Completed

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00305864

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 106 locations
View Trial Details
Completed

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

NCT00045110

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +28 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions